🇺🇸 FDA
Patent

US 11117934

Oncolytic virus platform to treat cancers with myxoma virus

granted A61KA61K2039/5154A61K2039/5256

Quick answer

US patent 11117934 (Oncolytic virus platform to treat cancers with myxoma virus) held by ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Sep 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K2039/5154, A61K2039/5256, A61K2039/545, A61K2039/572